REGISTERED
on 05 Dec 2023
Last Applicant/ Owned by
20251 Hamburg
DE
Serial Number
79340988 filed on 23rd Aug 2021
Registration Number
7232511 registered on 05th Dec 2023
Correspondent Address
R. Glenn Schroeder
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
NRAVEL
Collection of clinical data for medical research and development of therapeutics and diagnostics; collecting genetic, medical, biomedical, biologic, chemical and biochemical data and information, in particular information generated through the use of imaging techniques, the use of liquid biopsy methods, the use of histopathological analysis and procedures, the use of genetic analysis and the use o Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical analyses in connection with the treatment of individuals including medical analysis of X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes; medical clinic services; pharmaceutical advisory services; medical analysis services using bioinformatics and computational biology, for patient diagnostic and treatment purposes; providing supporting services and advice to hospitals and other medical care centres, namely, collecting and stabilizing of human and animal biospecimens, providing advice related thereto, and the collection of related clinical data for patient diagnostic and treatment purposes; all the afore-mentioned in particular with regard to the field of oncology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Collection of clinical data for medical research and development of therapeutics and diagnostics; collecting genetic, medical, biomedical, biologic, chemical and biochemical data and information, in particular information generated through the use of imaging techniques, the use of liquid biopsy methods, the use of histopathological analysis and procedures, the use of genetic analysis and the use of genomics, proteomics, transcriptomics, metabolomics, lipidomics and/or glycomics studies and analysis for medical research; scientific and technological services, namely, research, design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial analysis and research services in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, namely, molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods for research purposes; preparation of human and animal biospecimen for research purposes; providing information and data relating to medical and veterinary research on human and animal biospecimen, in particular genomic, epigenomic, proteomic, phosphoproteomic, RNA, transcriptomic, lipidomic and metabolomic data; medical laboratory services for medical research purposes, other than for diagnostic or treatment purposes, namely, typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods; database design and development; software as a service (SAAS) services, namely, hosting software for use by others for use as a database; installation, maintenance and updating of database software; providing scientific research information and results from an online searchable database; programming of computer software for databases; scientific and laboratory analysis using bioinformatics and computational biology in the field of oncology; all the afore-mentioned in particular with regard to the field of oncology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample materials, for medical purposes, namely, tumor tissues and tissue grafts samples, blood, serum, plasma, urine, stools, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; test kits of human and animal sample materials, comprising diagnostic reagents for medical purposes, namely, human and animal allograft and xenograft tissue, tissue cuts being biological tissue grafts and biological tissue cultures, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for medical use; therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods, for medical use for the treatment of cancer; biological material collections, namely, biological tissue cultures for medical purposes; cancer material collections, namely, biological tissue being resected and biopsy tumor and adjacent non-tumor tissue from the human body including epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; medical sample collections, namely, biological tissue cultures for medical purposes; biological sample collections from the human body, namely, epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; biopsy material collections, namely, biological tissue in the nature of blood, biological tissue grafts and biological tissue cultures for medical purposes; all the afore-mentioned in particular with regard to the field of oncology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79340988
Mark Type
No Service Mark
Attorney Docket Number
No 115-20
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th May 2024 | USPTO CORRECTION PROCESSED BY IB |
| 23rd Apr 2024 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |
| 08th Apr 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 14th Mar 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 14th Mar 2024 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| 14th Mar 2024 | FINAL DISPOSITION PROCESSED |
| 13th Mar 2024 | CORRECTION UNDER SECTION 7 - PROCESSED |
| 05th Mar 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 05th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 05th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |